Mesalazine/thalidomideLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1853卷 / 1期

关键词：

D O I：

10.1007/s40278-021-95157-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：291 / 291

相关论文

共 50 条

[31] Gliclazide/Mesalazine/MetforminItchy rash and lack of efficacy: case report
Reactions Weekly, 2024, 2028 (1) : 230 - 230
[32] Mesalazine/prednisolone/steroidsVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2023, 1945 (1) : 314 - 314
[33] Corticosteroids/mesalazine/vedolizumabImmunoglobulin A vasculitis and lack of efficacy: case report
Reactions Weekly, 2024, 2029 (1) : 188 - 188
[34] Infliximab/mesalazine/methotrexateLack of efficacy and miliary TB: case report
Reactions Weekly, 2022, 1909 (1) : 292 - 292
[35] Budesonide/mesalazine/ustekinumabRenal dysfunction and lack of efficacy: case report
Reactions Weekly, 2024, 2024 (1) : 105 - 105
[36] Azathioprine/mesalazine/prednisoloneLack of efficacy and treatment failure: case report
Reactions Weekly, 2025, 2055 (1) : 66 - 66
[37] Antivirals/foscarnet/thalidomideLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1960 (1) : 67 - 67
[38] Mesalazine/prednisolone/qingdai-compoundPseudomelanosis and lack of efficacy: case report
Reactions Weekly, 2022, 1888 (1) : 226 - 226
[39] Infliximab/mesalazine/vedolizumabLack of efficacy and acute tubulointerstitial nephritis: case report
Reactions Weekly, 2023, 1971 (1) : 137 - 137
[40] Mesalazine/rivaroxabanElevated international normalised ratio and lack of efficacy: case report
Reactions Weekly, 2023, 1976 (1) : 206 - 206

← 1 2 3 4 5 →